Finbar Larkin - Net Worth and Insider Trading

Finbar Larkin Net Worth

The estimated net worth of Finbar Larkin is at least $2 Million dollars as of 2024-09-21. Finbar Larkin is the SVP, Technical Operations of Jazz Pharmaceuticals PLC and owns about 21,779 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $2 Million. Details can be seen in Finbar Larkin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Finbar Larkin has not made any transactions after 2023-03-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Finbar Larkin

To

Finbar Larkin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Finbar Larkin owns 1 companies in total, including Jazz Pharmaceuticals PLC (JAZZ) .

Click here to see the complete history of Finbar Larkin’s form 4 insider trades.

Insider Ownership Summary of Finbar Larkin

Ticker Comapny Transaction Date Type of Owner
JAZZ Jazz Pharmaceuticals PLC 2023-03-07 SVP & Technical Development

Finbar Larkin Latest Holdings Summary

Finbar Larkin currently owns a total of 1 stock. Finbar Larkin owns 21,779 shares of Jazz Pharmaceuticals PLC (JAZZ) as of March 7, 2023, with a value of $2 Million.

Latest Holdings of Finbar Larkin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
JAZZ Jazz Pharmaceuticals PLC 2023-03-07 21,779 110.76 2,412,242

Holding Weightings of Finbar Larkin


Finbar Larkin Form 4 Trading Tracker

According to the SEC Form 4 filings, Finbar Larkin has made a total of 11 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 3,781 shares on March 7, 2023, which brought Finbar Larkin around $537,620.

Insider Trading History of Finbar Larkin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Finbar Larkin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Finbar Larkin Ownership Network

Ownership Network List of Finbar Larkin

No Data

Ownership Network Relation of Finbar Larkin

Insider Network Chart

Finbar Larkin Owned Company Details

What does Jazz Pharmaceuticals PLC do?

Who are the key executives at Jazz Pharmaceuticals PLC?

Finbar Larkin is the SVP & Technical Development of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include SVP & Technical Operations Mary Elizabeth Henderson , VP & Finance& PAO Patricia Carr , and SVP & General Counsel Neena M Patil .

Jazz Pharmaceuticals PLC (JAZZ) Insider Trades Summary

Over the past 18 months, Finbar Larkin made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 4,293 shares made by Patricia Carr , a net sale of 8,850 shares made by Neena M Patil , and a net sale of 1,658 shares made by Mark Douglas Smith .

In summary, during the past 3 months, insiders sold 1,410 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 0 shares, with a net sale of 1,410 shares. During the past 18 months, 33,900 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 21,900 shares.

Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jazz Pharmaceuticals PLC Insider Transactions

No Available Data

Finbar Larkin Mailing Address

Above is the net worth, insider trading, and ownership report for Finbar Larkin. You might contact Finbar Larkin via mailing address: 3170 Porter Drive, Palo Alto Ca 94304.

Discussions on Finbar Larkin

No discussions yet.